Insider · CIK 0001569248
Burow Kristina
Reports to the SEC for 22 companies · CHICAGO, IL
Transactions
50
Companies
22
Filings
5
CIK
0001569248
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-01 | SRRKScholar Rock Holding CorpS Sale | −$51.5K |
| 2026-07-01 | SRRKScholar Rock Holding CorpS Sale | −$113K |
| 2026-06-04 | SRRKScholar Rock Holding CorpA Award | — |
| 2026-06-04 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award | — |
| 2026-05-27 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-04-23 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-23 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-23 | SRRKScholar Rock Holding CorpM Exercise/Conversion | +$328K |
| 2026-04-23 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-23 | SRRKScholar Rock Holding CorpM Exercise/Conversion | +$209K |
| 2026-04-23 | SRRKScholar Rock Holding CorpM Exercise/Conversion | +$133K |
| 2026-04-23 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-23 | SRRKScholar Rock Holding CorpM Exercise/Conversion | +$150K |
| 2025-11-13 | MTSRMetsera, Inc. · Restricted Stock UnitA Award | — |
| 2025-11-13 | MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc.D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc.D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc.D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc.D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-11-13 | MTSRMetsera, Inc.D Disposition to Issuer | — |
| 2025-10-27 | NMRANeumora Therapeutics, Inc.P Purchase | +$5M |
| 2025-06-23 | BOLDBoundless Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-29 | SRRKScholar Rock Holding CorpS Sale | −$131K |
| 2025-05-29 | SRRKScholar Rock Holding CorpS Sale | −$29.2K |
| 2025-05-28 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-28 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-28 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-05-28 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-28 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-05-22 | SRRKScholar Rock Holding CorpA Award | — |
| 2025-05-22 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award | — |
| 2025-05-20 | MTSRMetsera, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-13 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-13 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-13 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-13 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-03 | MTSRMetsera, Inc.C Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc.P Purchase | +$25.8M |
| 2025-02-03 | MTSRMetsera, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc.C Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc.P Purchase | +$14.2M |
| 2025-02-03 | MTSRMetsera, Inc. · Series Seed Preferred StockC Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2025-02-03 | MTSRMetsera, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2024-06-27 | SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award | — |
| 2024-06-27 | SRRKScholar Rock Holding CorpA Award | — |
| 2024-06-13 | NMRANeumora Therapeutics, Inc.A Award | — |
| 2024-06-13 | NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Burow Kristina0001193125-26-296248SEC(opens sec.gov)
- 4Burow Kristina0001104659-26-071428SEC(opens sec.gov)
- 4Burow Kristina0001610717-26-000174SEC(opens sec.gov)
- 4Burow Kristina0001104659-26-048551SEC(opens sec.gov)
- 4Burow Kristina0001193125-25-280808SEC(opens sec.gov)
Companies
- Beam Therapeutics Inc.DirectorBEAM
- Boundless Bio, Inc.10% OwnerBOLD
- CITY THERAPEUTICS, INC.10% OwnerCTY
- DA32 Life Science Tech Acquisition Corp.10% Owner
- Erasca, Inc.10% OwnerERAS
- Gossamer Bio, Inc.DirectorGOSS
- Kardigan, Inc.Director, 10% OwnerKARD
- Lyell Immunopharma, Inc.10% OwnerLYEL
- Maze Therapeutics, Inc.10% OwnerMAZE
- Metacrine, Inc.Director
- Metsera, Inc.DirectorMTSR
- Neumora Therapeutics, Inc.Director, 10% OwnerNMRA
- Prime Medicine, Inc.10% OwnerPRME
- Rapport Therapeutics, Inc.10% OwnerRAPP
- Receptos, Inc.Director
- Sana Biotechnology, Inc.10% OwnerSANA
- Scholar Rock Holding CorpDirectorSRRK
- Seaport Therapeutics, Inc.10% OwnerSPTX
- Sienna Biopharmaceuticals, Inc.Director, 10% Owner
- Unity Biotechnology, Inc.Director
- Verve Therapeutics, Inc.10% Owner
- Vir Biotechnology, Inc.DirectorVIR
Address
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO, IL, 60631